IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results
1. IRMD reports record revenue of $20.4 million for Q2 2025, up 14%. 2. GAAP EPS increased 18% to $0.45, signaling strong financial health. 3. Quarterly dividend of $0.17 announced, reinforcing shareholder commitment. 4. Raised full-year 2025 revenue guidance to $80.0-$82.5 million. 5. Operational inefficiencies expected from new facility transition in Q3 2025.